oral semaglutide 50 mg oasis 1 nejm 2023 obesity Novel strategies for medical management of obesity: mechanisms, clinical implications, and societal impacts—a report from the 25th Annual Harvard Nutrition Symposium Oral vs. Injectable Semaglutide: Effectiveness

Even so, a patch test is still recommended for new patients

For psychiatric providers specifically, theres a unique opportunity here

Efficacy and safety of semaglutide for weight management: evidence from the STEP program

Those with unstable psychiatric conditions or active substance use disorders require careful evaluation before starting appetite modifying medications

These combined effects make GLP-1 a powerful regulator of metabolism and body weight

While the majority of the literature surrounding GLP-1/GIP receptor agonists has focused on Type 2 Diabetes (T2D), there is a growing body of evidence exploring their potential in Type 1 Diabetes (T1D), particularly in individuals with overweight or obesity